Mandate

Vinge has advised Aprea Therapeutics in connection with its listing on Nasdaq, New York

Vinge has advised Aprea Therapeutics, Inc. and its subsidiary Aprea Therapeutics AB in connection with its listing on Nasdaq, New York.

The initial public offering price was set to $15 and the biopharmaceutical company sold 6.5 million shares in the IPO to raise $97.75 million. Aprea Therapeutics, Inc. is a biopharmaceutical company headquartered in Boston, Massachusetts with research facilities in Stockholm, Sweden, focused on developing and commercializing cancer therapeutics.

 
Vinge’s team has primarily consisted of Kristina Ekberg, Charlotte Levin, Maria Schultzberg, Anna Thoms and Stina Bengtsson.

Related

Vinge advises Zellis Group, a portfolio company of Apax Partners, in connection with the acquisition of Benify

Vinge has, together with Kirkland & Ellis, advised Zellis Group, a portfolio companya of funds advised by Apax Partners LLP (“Apax”), in connection with the acquisition of Benify, a provider of employee benefits administration software, from Vitruvian Partners and the other shareholders.
September 09, 2024

Vinge advises Blue Wolf Capital Partners in connection with the acquisition of seven manufacturing and development facilities from Recipharm

Vinge has, together with Kirkland & Ellis, advised Blue Wolf Capital Partners LLC (“Blue Wolf”), a middle market private equity firm specializing in the healthcare and industrial sectors, in connection with the acquisition of seven manufacturing and development facilities in Sweden, France, and Spain, from Recipharm Group, a contract development and manufacturing organization (“CDMO”) headquartered in Stockholm.
September 03, 2024

Vinge advises on the sale of Märta Måås-Fjetterström’s business

Vinge has advised the Swedrup family in connection with the sale of Märta Måås-Fjetterström, Verkstaden för svenska mattor och vävnader Aktiebolag. The company manufactures rugs and tapestries in Båstad based on designs by both Märta Måås-Fjetterström herself and her successors, such as Barbro Nilsson, Marianne Richter, Ann-Mari Forsberg and others. The buyer is the Hult family.
September 03, 2024